Skip to main content
Quest Diagnostics

Overlapping Symptoms of Respiratory Infections and COVID-19—What You Need to Know

Date: Tuesday, Oct 20, 2020

Description: Presented by: William A. Meyer III, PhD, D (ABMM), MLS (ASCP) Moderated by: Hema Kapoor, MD, D (ABMM), SM

Program objectives

  • At the conclusion of this program, participants will be able to: 
  • Explain the most current updates on SARS-CoV-2 ( COVID-19) testing
  •  Explain the overlapping symptoms of respiratory infections, and the role of various molecular testing as the influenza season and COVID pandemic collide 
  • Understand the combination of diagnostic tests for influenza season

NOTE: Clients should refer to the Quest Test Directory for updates related to transport and stability of tests highlighted in the webinar.

Authors:

Kapoor, Hema, MD SM, D(ABMM)
Senior Medical Director
Infectious Diseases & Immunology and Global Diagnostics Network
Quest Diagnostics, Secaucus, New Jersey 

Meyer III, William A., PhD, D(ABMM), MLS(ASCP)CM
Director, Medical Science Liaison, Infectious Diseases/Immunology
Technical Director- Quest Diagnostics, East Region
Baltimore, Maryland 

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.